alexa Role Of Pharma Industries In The Improvement Of Pharmacovigilance System | 22937
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials

Pranjal Bordoloi
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.012
Abstract
Before a medicine is authorized for use, evidence of its safety and efficacy is limited to the results from clinical trials and preclinical studies. This means that at the time of a medicine?s authorization, it will only have been tested in a relatively small number of patients of a specific group, for a limited length of time. Once a product has been authorized and marketed a key role in the ongoing activity of pharmacovigilance. Some side effects or ?adverse reactions? may not be seen until a very large number of people have received the medicine and used it over longer time periods in real life use often in more diverse populations and with more concomitant medications than used in clinical trials. The real life use of medicines only happens once healthcare professionals begin prescribing. It is therefore vital that the safety of all medicines is monitored throughout their use in healthcare practice with a robust Pharmacovigilance systeM.Pharmacovigilance system to be functional and efficient, all the stakeholders including, but not limiting to, regulatory bodies, manufacturer and health care professionals need to be alert and attentive throughout the lifetime of the drug in the market. The pharmaceutical industry has prime responsibility for the safety of medicines. Manufacturers are uniquely placed for monitoring the safety of medicines, from the start of drug development and thereafter throughout the lifetime of the drug. Pharmaceutical and biotechnology companies must not only monitor, but also proactively scrutinize and manage drug risk throughout a product?s lifecycle, from development to post market. There should be an interest by stakeholders to enhance patient care and patient safety in relation to the use of medicines; and to support public health programs by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.
Biography
Pranjal Bordoloi is a trained MD in Pharmacology, with more than 12 years of experience in working with Pharma, Biotech and CROs of global repute. He has vast experience in various therapeutic areas and has played key roles in Clinical Trial Management, Medical & Regulatory Affairs and Pharmacovigilance. He has successfully lead the designing, strategizing and execution of various phases of drug development from preclinical studies to post marketing safety monitoring. Currently, he is head of Pharmacovigilance operations at Lambda Therapeutic Research Ltd.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version